Literature DB >> 4957

Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension.

P Lund-Johansen.   

Abstract

Sixteen men with previously untreated essential hypertension in WHO stage I have been studied as out-patients. Oxygen consumption, heart rate (HR), cardiac output (Q) (Cardiogreen) and intraarterial brachial pressure were recorded at rest in supine and sitting position and during steady state work at 300, 600 and 900 kpm/min. The subjects were treated with timolol as the sole drug for one year and the hemodynamic study was repeated. BP was reduced approximately 18% at rest and 14% during exercise, HR approximately 26% and the cardiac index 28% at rest supine and 32% at rest sitting. During exercise the reductions in Q were 25-30%. The calculated total peripheral resistance was significantly increased at rest as well as during exercise. The product of mean arterial pressure and HR was reduced about 40%. No severe side-effects were seen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4957     DOI: 10.1111/j.0954-6820.1976.tb06730.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

5.  Vasodilatation in hypertension: the relevance of ISA. Concluding paper.

Authors:  A Zanchetti
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

6.  Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.

Authors:  P Lund-Johansen; O M Bakke
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

7.  Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  Possible significance of the pharmacological differentiation of beta-blockers for therapy of hypertension.

Authors:  F H Leenen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

9.  Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen; O J Ohm
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 10.  Salt sensitivity and hypertension.

Authors:  Olga Balafa; Rigas G Kalaitzidis
Journal:  J Hum Hypertens       Date:  2020-08-29       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.